Farmax India Limited Reports Audited Standalone Earnings Results for the Fourth Quarter and Year and Consolidated Earnings Results for the Year Ended March 31, 2015
For the year, on standalone basis, the company reported total income from operations of INR 210.456 million compared to INR 174.054 million a year ago. Loss from operations before other income and exceptional items was INR 38.853 million compared to INR 92.210 million a year ago. Loss from ordinary activities before tax was INR 21.011 million compared to INR 88.430 million a year ago. Net loss for the period was INR 21.011 million or INR 0.04 per basic and diluted share before and after extraordinary items compared to INR 88.430 million or INR 0.22 per basic and diluted share before and after extraordinary items a year ago.
For the year, on consolidated basis, the company reported total income from operations of INR 210.456 million compared to INR 174.054 million a year ago. Loss from operations before other income and exceptional items was INR 39.276 million compared to INR 92.618 million a year ago. Loss from ordinary activities before tax was INR 21.434 million compared to INR 88.839 million a year ago. Net loss for the period was INR 21.434 million or INR 4.03 per basic and diluted share before and after extraordinary items compared to INR 88.839 million or INR 4.03 per basic and diluted share before and after extraordinary items a year ago.